Further work involving hematopoietic-specific Il18−/−/Il18r1−/−/Il18bp−/− mice is now required to better evaluate the intrahepatic contribution of IL-18BP in MASH progression. Here, IL18BP is linked to metabolic dysfunction-associated steatohepatitis.